Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
American Journal of Respiratory and Critical Care Medicine|June 23, 2016
Mortality due to Respiratory Syncytial Virus. Burden and Risk FactorsSarah Geoghegan, Anabella Erviti, Mauricio T Caballero, et al.
Nature Medicine|December 7, 2010
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexesAna Clara Monsalvo, Juan P Batalle, M Florencia Lopez, et al.
The New England Journal of Medicine|December 10, 2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineFernando P Polack, Stephen J Thomas, Nicholas Kitchin, et al.
The New England Journal of Medicine|April 5, 2023
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older AdultsEdward E Walsh, Gonzalo Pérez Marc, Agnieszka M Zareba, et al.
The New England Journal of Medicine|September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 MonthsStephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2021
Global Respiratory Syncytial Virus-Related Infant Community DeathsNatalie I Mazur, Yvette N Löwensteyn, Joukje E Willemsen, et al.
The Lancet. Infectious Diseases|June 20, 2018
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidatesNatalie I Mazur, Deborah Higgins, Marta C Nunes, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2013
Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in childrenF Martín Ferolla, Diego R Hijano, Patricio L Acosta, et al.
Nature Communications|July 24, 2019
Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon responseKrist Helen Antunes, José Luís Fachi, Rosemeire de Paula, et al.
Obstetrics and Gynecology|January 2, 2025
Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine TrialEric A F Simões, Barbara A Pahud, Shabir A Madhi, et al.
Pageof 12